CDC greenlights third Pfizer/Moderna vaccine dose for immunocompromised individuals; schedules Aug. 17 call for clinicians
![cdc-update](/sites/default/files/styles/900x400/public/2018-07/cdc-update.jpg?itok=0cRUeHuZ)
Centers for Disease Control and Prevention Director Rochelle Walensky, M.D., late Friday authorized a third, additional dose of the mRNA COVID-19 vaccines for people with moderately to severely compromised immune systems. This includes people who have:
- been receiving active cancer treatment for tumors or cancers of the blood;
- received an organ transplant and are taking medicine to suppress the immune system;
- received a stem cell transplant within the last two years or are taking medicine to suppress the immune system;
- moderate or severe primary immunodeficiency (such as DiGeorge syndrome, Wiskott-Aldrich syndrome);
- advanced or untreated HIV infection; and
- are undergoing active treatment with high-dose corticosteroids or other drugs that may suppress your immune response.
CDC Tuesday, Aug. 17, at 2 p.m. ET will hold a call for clinicians to discuss additional doses, along with the current data on COVID-19 vaccines in immunocompromised people. Clinicians can follow this link to participate; a recording also will be available on the COCA Call webpage a few hours after the live event ends.
Related News Articles
Headline
The Centers for Disease Control and Prevention Aug. 13 issued an advisory alerting of an uptick of cases of parvovirus B19 across the U.S. Parvovirus B19 is a…
Headline
Adults age 65 and older are encouraged to receive an updated dosage of the COVID-19 vaccine, the Centers for Disease Control and Prevention announced April 25…
Headline
The Pfizer and Moderna COVID-19 vaccines can cause myocarditis, but do not appear to cause infertility, Guillain-Barré syndrome, Bell’s palsy, thrombosis with…
Headline
Centers for Disease Control and Prevention Director Mandy Cohen, M.D., Feb. 28 endorsed a recommendation by its Advisory Committee on Immunization Practices…
Headline
Paxlovid may no longer be distributed with an emergency use label after March 8, the Food and Drug Administration announced. Providers may dispense unexpired…
Headline
A CDC study released Dec. 21 found low COVID-19 and flu vaccination coverage for most adults, and low RSV vaccination coverage for adults aged 60 and…